Amarin (AMRN)
(Real Time Quote from BATS)
$19.26 USD
+0.42 (2.23%)
Updated Oct 6, 2025 03:52 PM ET
2-Buy of 5 2
C Value B Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AMRN 19.26 +0.42(2.23%)
Will AMRN be a Portfolio Killer in October?
Zacks Investment Research is releasing its prediction for AMRN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMRN
Amarin (AMRN) Surges 12.5%: Is This an Indication of Further Gains?
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
AMRN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Prothena (PRTA) Up 17.6% Since Last Earnings Report: Can It Continue?
Is Amarin (AMRN) Stock Outpacing Its Medical Peers This Year?
RCKT Stock Rises as FDA Lifts Clinical Hold on Danon Disease Study
Other News for AMRN
AMRN makes New 52 Week Closing High on October 3
Is AMRN preparing to trend higher? Pocket Pivot shows up after climbing 1.86%
AMRN forms Pocket Pivot on October 1
AMRN forms Pocket Pivot on September 30
Pocket Pivot appears for AMRN after 0.5% move